Deal Valuation




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Deal Valuation
Released on: August 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this month's Business Report, we assess the valuation methodologies used in deal transactions for assets such as drugs in development, whole pipelines or business assets.
  • Summary
  • Transcript
  • Company
In this month's Business Report, we assess the valuation methodologies used in deal transactions for assets such as drugs in development, whole pipelines or business assets. We use data sourced from PharmaVentures' proprietary deal information resource, PharmaDeals® Agreements, to look briefly at some of the trends in shifting deal values for licensing deals and for products in different therapeutic areas.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK